Hunan Jingfeng Pharmaceutical (000908) - Cash Flow Conversion Efficiency

Latest as of September 2025: -3.332x

Based on the latest financial reports, Hunan Jingfeng Pharmaceutical (000908) has a cash flow conversion efficiency ratio of -3.332x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥125.78 Million ≈ $18.41 Million USD) by net assets (CN¥-37.76 Million ≈ $-5.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Hunan Jingfeng Pharmaceutical to measure how many days the company can operate on defensive assets alone.

Hunan Jingfeng Pharmaceutical - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Hunan Jingfeng Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hunan Jingfeng Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hunan Jingfeng Pharmaceutical ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Kingfa Science & Technology (India) Limited
NSE:KINGFA
0.078x
Shandong Link Science and Technology Co Ltd
SHE:001207
0.032x
Apogee Enterprises Inc
NASDAQ:APOG
0.109x
Beijing Utour International Travel Service Co Ltd
SHE:002707
0.167x
Sun Create Electronics Co., Ltd
SHG:600990
0.058x
Hangzhou Star Shuaier Electric Appliance Co Ltd
SHE:002860
-0.007x
Nufarm Ltd
AU:NUF
-0.169x
Tanla Platforms Limited
NSE:TANLA
0.074x

Annual Cash Flow Conversion Efficiency for Hunan Jingfeng Pharmaceutical (1999–2024)

The table below shows the annual cash flow conversion efficiency of Hunan Jingfeng Pharmaceutical from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Hunan Jingfeng Pharmaceutical worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥-15.13 Million
≈ $-2.21 Million
CN¥-5.55 Million
≈ $-812.28K
0.367x +260.81%
2023-12-31 CN¥-153.68 Million
≈ $-22.49 Million
CN¥35.06 Million
≈ $5.13 Million
-0.228x -139.76%
2022-12-31 CN¥214.83 Million
≈ $31.44 Million
CN¥123.27 Million
≈ $18.04 Million
0.574x +51.85%
2021-12-31 CN¥327.73 Million
≈ $47.96 Million
CN¥123.83 Million
≈ $18.12 Million
0.378x +188.76%
2020-12-31 CN¥638.18 Million
≈ $93.39 Million
CN¥-271.68 Million
≈ $-39.76 Million
-0.426x -2385.47%
2019-12-31 CN¥1.94 Billion
≈ $284.15 Million
CN¥36.17 Million
≈ $5.29 Million
0.019x -84.81%
2018-12-31 CN¥2.86 Billion
≈ $418.81 Million
CN¥350.94 Million
≈ $51.35 Million
0.123x +110.21%
2017-12-31 CN¥2.60 Billion
≈ $380.45 Million
CN¥151.65 Million
≈ $22.19 Million
0.058x +1136.37%
2016-12-31 CN¥2.61 Billion
≈ $382.27 Million
CN¥12.32 Million
≈ $1.80 Million
0.005x -88.52%
2015-12-31 CN¥2.25 Billion
≈ $329.02 Million
CN¥92.37 Million
≈ $13.52 Million
0.041x -80.17%
2014-12-31 CN¥994.04 Million
≈ $145.46 Million
CN¥205.93 Million
≈ $30.13 Million
0.207x +131.95%
2013-12-31 CN¥5.31 Million
≈ $776.82K
CN¥-3.44 Million
≈ $-503.70K
-0.648x -10996.71%
2012-12-31 CN¥-60.15 Million
≈ $-8.80 Million
CN¥351.50K
≈ $51.44K
-0.006x +99.93%
2011-12-31 CN¥790.82K
≈ $115.72K
CN¥-6.87 Million
≈ $-1.01 Million
-8.689x -3203.30%
2010-12-31 CN¥57.85 Million
≈ $8.46 Million
CN¥-15.21 Million
≈ $-2.23 Million
-0.263x -122.84%
2009-12-31 CN¥100.67 Million
≈ $14.73 Million
CN¥-11.88 Million
≈ $-1.74 Million
-0.118x -228.87%
2008-12-31 CN¥338.64 Million
≈ $49.55 Million
CN¥31.02 Million
≈ $4.54 Million
0.092x -40.95%
2007-12-31 CN¥336.95 Million
≈ $49.31 Million
CN¥52.26 Million
≈ $7.65 Million
0.155x -9.89%
2006-12-31 CN¥336.40 Million
≈ $49.23 Million
CN¥57.90 Million
≈ $8.47 Million
0.172x +195.38%
2005-12-31 CN¥329.66 Million
≈ $48.24 Million
CN¥-59.49 Million
≈ $-8.71 Million
-0.180x +60.83%
2004-12-31 CN¥339.45 Million
≈ $49.67 Million
CN¥-156.37 Million
≈ $-22.88 Million
-0.461x -958.22%
2003-12-31 CN¥419.38 Million
≈ $61.37 Million
CN¥22.51 Million
≈ $3.29 Million
0.054x +59.52%
2002-12-31 CN¥522.69 Million
≈ $76.49 Million
CN¥17.59 Million
≈ $2.57 Million
0.034x -45.02%
2001-12-31 CN¥498.41 Million
≈ $72.93 Million
CN¥30.50 Million
≈ $4.46 Million
0.061x +222.29%
2000-12-31 CN¥500.54 Million
≈ $73.24 Million
CN¥-25.05 Million
≈ $-3.67 Million
-0.050x -278.13%
1999-12-31 CN¥485.43 Million
≈ $71.03 Million
CN¥13.64 Million
≈ $2.00 Million
0.028x --

About Hunan Jingfeng Pharmaceutical

SHE:000908 China Drug Manufacturers - General
Market Cap
$750.55 Million
CN¥5.13 Billion CNY
Market Cap Rank
#10351 Global
#2826 in China
Share Price
CN¥5.83
Change (1 day)
-2.67%
52-Week Range
CN¥4.58 - CN¥9.23
All Time High
CN¥16.99
About

Hunan Jingfeng Pharmaceutical Co.,Ltd. manufactures and sells chemical drugs and biological agents in China. The company's principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmic equipment and API products, as well as engages in the research and development of antitumor, cancer, and cardiovascular drugs; and distributed in the f… Read more